Loeb & Loeb LLP is proud to announce that partner Mark Waddell will be speaking at the ACI 8th Annual Maximizing Pharmaceutical Patent Life Cycles program.
From the ACI website:
The rules of the pharmaceutical patent endgame are changing rapidly. Pharmaceutical patent expirations equaling $140 Billion in losses will occur within the next ten years. Congress, the PTO and the Courts are now reshaping the current pharmaceutical patent schematic. A new pharmaceutical patent paradigm is about to emerge.
Come to the only event that will enable brand name and generic drug makers to benchmark their companies' current Hatch-Waxman strategies against this new paradigm.